. Author manuscript; available in PMC: 2018 Dec 1.

Published in final edited form as: Obstet Gynecol. 2017 Dec;130(6):1218–1225. doi: 10.1097/AOG.0000000000002330

Table 5.

CIN2⁺ yield by ECC when performed according to indications in the current cervical cancer screening and management guidelines¹¹

	Indication	N	CIN2⁺ Yield by ECC (n;%)
Cervical Cytology	Colposcopic Impression/% SCJ Visualized

ASCUS or LSIL	No lesion identified on colposcopy (preferred)	23	1 (4.3)
	Unsatisfactory colposcopy (preferred)	46	6 (13.0)
	Satisfactory colposcopy and lesion identified (acceptable)	53	1 (1.9)

ASC-H or HSIL⁺	All non-pregnant women of screening age	62	16 (25.8)

ASC-US = atypical squamous cells of undetermined significance; LSIL = low-grade squamous intraepithelial lesion; AGC = atypical glandular cells; AIS = adenocarcinoma in situ; SCC = squamous cell carcinoma. HSIL⁺ includes HSIL, AGC, and SCC cytology. SCJ = squamo-columnar junction.